2,269
Views
26
CrossRef citations to date
0
Altmetric
Reviews

Prognostic value of circulating microRNA-21 for breast cancer: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1216-1221 | Received 11 Apr 2016, Accepted 21 Jul 2016, Published online: 16 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Pradana Zaky Romadhon, Ami Ashariati Prayoga, Siprianus Ugroseno Yudho Bintoro, Muhammad Noor Diansyah, Putu Niken Ayu Amrita, Merlyna Savitri, Satriyo Dwi Suryantoro, Kartika Prahasanti, Andi Yasmin Wijaya, Winona May Hendrata, Choirina Windradi, Bagus Aulia Mahdi, Krisnina Nurul Widiyastuti & Esthiningrum Dewi Agustin. (2022) Prognosticating 2-Year Survival Rate of Breast Cancer Patients Through Plasma miRNA-21 and Other Associating Factors. International Journal of General Medicine 15, pages 5557-5566.
Read now
Berrin Papila Kundaktepe, Volkan Sozer, Cigdem Papila, Sinem Durmus, Pinar Cigdem Kocael, Gonul Simsek, Remise Gelisgen, Kagan Zengin, Kenan Ulualp & Hafize Uzun. (2020) Associations Between miRNAs and Two Different Cancers: Breast and Colon. Cancer Management and Research 12, pages 871-879.
Read now
Li-Pei Wu, Jian Wu, Anquan Shang, Man Yang, Ling-Ling Li, Jing Yu, Lei-Rong Xu, Chun-Bing Wang, Wei-Wei Wang, Jian-Jun Zhu & Wen-Ying Lu. (2018) miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 159-167.
Read now
Yu Liu, Lili Han, Yahui Bai, Wei Du & Bo Yang. (2018) Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma. Artificial Cells, Nanomedicine, and Biotechnology 46:1, pages 206-210.
Read now

Articles from other publishers (21)

Afshin Bahramy, Narges Zafari, Fatemeh Rajabi, Amirhossein Aghakhani, Ahmad Jayedi, Alireza Soltani Khaboushan, Masoumeh Majidi Zolbin & Mir Saeed Yekaninejad. (2023) Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis. Frontiers in Molecular Biosciences 10.
Crossref
Deeksha Agrawal, Roshani Kumari, Pooja Ratre, Afreen Rehman, Rupesh Kumar Srivastava, Edyta Reszka, Irina Yu Goryacheva & Pradyumna Kumar Mishra. (2022) Cell-free circulating miRNAs-lncRNAs-mRNAs as predictive markers for breast cancer risk assessment in women exposed to indoor air pollution. Case Studies in Chemical and Environmental Engineering 6, pages 100267.
Crossref
Zhou Hong, Jiaqi Cheng, Yong Ye, Xiaoqing Chen & Feng Zhang. (2022) MicroRNA-451 Attenuates the Inflammatory Response of Activated Microglia by Downregulating Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3. World Neurosurgery 167, pages e1128-e1137.
Crossref
Lap Hing Chi, Ryan S. N. Cross, Richard P. Redvers, Melissa Davis, Soroor Hediyeh-zadeh, Suresh Mathivanan, Monisha Samuel, Erin C. Lucas, Kellie Mouchemore, Philip A. Gregory, Cameron N. Johnstone & Robin L. Anderson. (2022) MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms. Oncogenesis 11:1.
Crossref
Barbara Cardinali, Roberta Tasso, Patrizia Piccioli, Maria Chiara Ciferri, Rodolfo Quarto & Lucia Del Mastro. (2022) Circulating miRNAs in Breast Cancer Diagnosis and Prognosis. Cancers 14:9, pages 2317.
Crossref
Zhi-Min Deng, Gan-Hong Chen, Fang-Fang Dai, Shi-Yi Liu, Dong-Yong Yang, An-Yu Bao & Yan-Xiang Cheng. (2022) The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets. PLOS ONE 17:4, pages e0267108.
Crossref
Jacob Sobota, Yingxue Zhang, Eid Alshammari & Zhe Yang. 2022. Genomic and Epigenomic Biomarkers of Toxicology and Disease. Genomic and Epigenomic Biomarkers of Toxicology and Disease 229 250 .
Matthew G. Davey, Gerard Feeney, Heidi Annuk, Maxwell Paganga, Emma Holian, Aoife J. Lowery, Michael J. Kerin & Nicola Miller. (2022) MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer. Cancers 14:9, pages 2109.
Crossref
M.Y. Cynthia Stafford, Colin E. WilloughbyColum P. Walsh & Declan J. McKenna. (2022) Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis. Bioscience Reports 42:1.
Crossref
PRIYANKA THAKUR, REENA V. SAINI, ANIL K. CHHILLAR, NEERAJ K. SAINI, VIJAY KUMAR THAKUR, SAMARJEET SINGH SIWAL & ADESH K. SAINI. (2022) Alteration in the expression of microRNA-21 regulated target genes: Role in breast cancer. BIOCELL 46:2, pages 309-324.
Crossref
Beatriz Suárez, Carla Solé, Maitane Márquez, Francesca Nanetti & Charles Henderson Lawrie. 2022. Systems Biology of MicroRNAs in Cancer. Systems Biology of MicroRNAs in Cancer 23 73 .
Maryam Koopaie, Fatemeh Abedinejad, Soheila Manifar, Reza Mousavi, Sajad Kolahdooz & Ahmadreza Shamshiri. (2021) Salivary miRNA-21 expression as a potential non-invasive diagnostic biomarker in breast cancer. Gene Reports 25, pages 101317.
Crossref
Aarthy Raghu, Arunagiri Kuha Deva Magendhra Rao, Thangarajan Rajkumar & Samson Mani. (2021) Prognostic Implications of microRNA-155, -133a, -21 and -205 in Breast Cancer Patients’ Plasma. MicroRNA 10:3, pages 206-218.
Crossref
Tomasz M. Grzywa, Klaudia Klicka & Paweł K. Włodarski. (2020) Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers 12:12, pages 3709.
Crossref
Zhen Zhang, Luoyan Zhang, Guoxiang Yu, Zhigang Sun, Tiantian Wang, Xingsong Tian, Xuening Duan & Chi Zhang. (2020) Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology 86:6, pages 761-772.
Crossref
Anna Maria Grimaldi, Silvia Nuzzo, Gerolama Condorelli, Marco Salvatore & Mariarosaria Incoronato. (2020) Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review. International Journal of Molecular Sciences 21:16, pages 5834.
Crossref
Vaishali Aggarwal, Kumari Priyanka & Hardeep Singh Tuli. (2020) Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers. Molecular Diagnosis & Therapy 24:2, pages 153-173.
Crossref
Eleni Zografos, Flora Zagouri, Despoina Kalapanida, Roubini Zakopoulou, Anastasios Kyriazoglou, Kleoniki Apostolidou, Maria Gazouli & Meletios-Athanasios Dimopoulos. (2019) Prognostic role of microRNAs in breast cancer: A systematic review. Oncotarget 10:67, pages 7156-7178.
Crossref
Andrea Ritter, Marc Hirschfeld, Kai Berner, Gerta R�cker, Markus J�ger, Daniela Weiss, Markus Medl, Claudia N�thling, Sandra Gassner, Jasmin Asberger & Thalia Erbes. (2019) Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?. International Journal of Oncology.
Crossref
Hui Ma, Li‐Yong Wang, Rong‐Hui Yang, Ying Zhou, Ping Zhou & Lu Kong. (2019) Identification of reciprocal microRNA‐mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis. Journal of Cellular Biochemistry 120:10, pages 17779-17790.
Crossref
Gustavo A. Rivas, Marcela C. Rodríguez, María D. Rubianes, Fabiana A. Gutierrez, Marcos Eguílaz, Pablo R. Dalmasso, Emiliano N. Primo, Cecilia Tettamanti, María L. Ramírez, Antonella Montemerlo, Pablo Gallay & Concepción Parrado. (2017) Carbon nanotubes-based electrochemical (bio)sensors for biomarkers. Applied Materials Today 9, pages 566-588.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.